Skip to main content
Watch Insiders
SMMTHealthcare

Summit Therapeutics Inc (SMMT) Insider Trading

In the last 90 days, no Summit Therapeutics Inc (SMMT) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 12, 2026Mahkam ZanganehCo-Chief Executive OfficerOpen Market Purchase3,810,000$13.12$49,987,200
Jun 12, 2026Robert W DugganCo-Chief Executive OfficerOpen Market Purchase3,810,000$13.12$49,987,200
Jun 4, 2026Manmeet Singh SoniCOO and CFOOpen Market Purchase50,000$14.45$722,250
Jun 4, 2026Mahkam ZanganehCo-Chief Executive OfficerOpen Market Purchase100,000$14.60$1,460,000
Jun 4, 2026Robert W DugganCo-Chief Executive OfficerOpen Market Purchase100,000$14.60$1,460,000

Common questions

SMMT insider trading FAQ

Are SMMT insiders buying or selling?
No SMMT insiders reported open-market purchases or sales in the last 90 days.
When was the last SMMT insider purchase?
No open-market insider purchase of Summit Therapeutics Inc stock was reported in the last 90 days.
Where does SMMT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Summit Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.